Back to search

Fistulating Anal Crohn's Disease: Results of Combined Surgical and Infliximab Treatment

Data up to Jan 2025

Published2006
Citations170
References25

Total Citations Per Year

Abstract

References (25)

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

2002 • 4,076 citations

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

2001 • 3,631 citations

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

1999 • 2,656 citations

Treatment of Crohn's Disease with 6-Mercaptopurine

1980 • 1,055 citations

The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients

2003 • 915 citations

Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration

2002 • 668 citations

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial

2003 • 561 citations

Healing of perineal Crohn's disease with metronidazole

1980 • 432 citations

Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease

2003 • 370 citations

Long-term treatment of rectovaginal fistulas in Crohn’s disease: Response to infliximab in the ACCENT II Study

2004 • 350 citations

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

2004 • 314 citations

Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group.

1995 • 300 citations

Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease

2003 • 290 citations

Usual Therapy Improves Perianal Crohn??s Disease as Measured by a New Disease Activity Index

1995 • 287 citations

An engineered human antibody to TNF (CDP571) for active Crohn's disease: A randomized double-blind placebo-controlled trial

2001 • 260 citations

Combined Seton Placement, Infliximab Infusion, and Maintenance Immunosuppressives Improve Healing Rate in Fistulizing Anorectal Crohn's Disease

2003 • 245 citations

Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double‐blind placebo‐controlled study

2004 • 240 citations

Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease

2000 • 215 citations

Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease

1991 • 175 citations

Perianal Crohn's disease

2004 • 156 citations

Perianal Crohn's disease

1980 • 114 citations

Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study

2006 • 112 citations

Infliximab in the surgical management of complex fistulating anal Crohn's disease

2005 • 92 citations

L’approche combinée médico-chirurgicale (séton + infliximab + azathioprine) : la panacée dans les lesions anopérinéales de Crohn ?

2005 • 33 citations

The safety profile of infliximab for Crohn's disease in clinical practice: The Mayo clinic experience in 500 patients

2003 • 15 citations

Cited By (0)

Loading...
Fistulating Anal Crohn's Disease: Results of Combined Surgical and Infliximab Treatment (2006) – Diseases of the Colon & Rectum | Metascience Observatory Explorer